X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21946) 21946
Book Review (3485) 3485
Publication (1304) 1304
Conference Proceeding (230) 230
Book Chapter (211) 211
Dissertation (82) 82
Magazine Article (58) 58
Newsletter (54) 54
Web Resource (32) 32
Book / eBook (24) 24
Paper (9) 9
Reference (9) 9
Data Set (6) 6
Trade Publication Article (4) 4
Newspaper Article (3) 3
Streaming Video (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14943) 14943
humans (13600) 13600
dyslipidemia (12123) 12123
male (9266) 9266
female (8475) 8475
risk factors (7022) 7022
middle aged (6525) 6525
adult (5157) 5157
cholesterol (4437) 4437
aged (4332) 4332
obesity (3752) 3752
hypertension (3436) 3436
metabolic syndrome (3412) 3412
lipids (3270) 3270
dyslipidemias - drug therapy (3250) 3250
diabetes (3112) 3112
dyslipidemias - blood (2881) 2881
prevalence (2750) 2750
atherosclerosis (2745) 2745
dyslipidemias - epidemiology (2683) 2683
animals (2656) 2656
insulin resistance (2640) 2640
cardiovascular disease (2566) 2566
dyslipidemias - complications (2519) 2519
diabetes mellitus (2298) 2298
cardiovascular diseases (2283) 2283
dyslipidemias (2280) 2280
risk (2161) 2161
endocrinology & metabolism (2156) 2156
cardiac & cardiovascular systems (2145) 2145
cardiovascular-disease (2128) 2128
lipids - blood (2078) 2078
insulin-resistance (2075) 2075
research (2054) 2054
triglycerides - blood (2047) 2047
body mass index (2039) 2039
coronary-heart-disease (2008) 2008
cholesterol, ldl - blood (1900) 1900
triglycerides (1843) 1843
statins (1786) 1786
pharmacology & pharmacy (1778) 1778
cholesterol, hdl - blood (1717) 1717
disease (1691) 1691
cross-sectional studies (1683) 1683
lipoproteins (1680) 1680
health aspects (1657) 1657
adolescent (1626) 1626
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1605) 1605
treatment outcome (1540) 1540
medicine, general & internal (1527) 1527
peripheral vascular disease (1508) 1508
mortality (1502) 1502
metabolism (1455) 1455
risk-factors (1445) 1445
inflammation (1425) 1425
analysis (1413) 1413
care and treatment (1398) 1398
hypolipidemic agents - therapeutic use (1357) 1357
cholesterol - blood (1353) 1353
blood pressure (1341) 1341
cardiovascular diseases - prevention & control (1337) 1337
prevention (1323) 1323
glucose (1314) 1314
hypertension - epidemiology (1294) 1294
type 2 diabetes (1291) 1291
young adult (1290) 1290
biomarkers - blood (1285) 1285
cardiovascular diseases - etiology (1265) 1265
low density lipoproteins (1244) 1244
nutrition & dietetics (1207) 1207
mice (1191) 1191
abridged index medicus (1185) 1185
biochemistry & molecular biology (1182) 1182
insulin (1182) 1182
dyslipidemias - metabolism (1161) 1161
medicine (1148) 1148
diet (1135) 1135
cardiovascular (1114) 1114
cardiovascular diseases - epidemiology (1111) 1111
physiological aspects (1101) 1101
oxidative stress (1098) 1098
association (1094) 1094
aged, 80 and over (1088) 1088
dyslipidemias - etiology (1059) 1059
child (1024) 1024
dyslipidemias - diagnosis (1024) 1024
rats (1022) 1022
hypercholesterolemia (1019) 1019
risk assessment (1006) 1006
density-lipoprotein cholesterol (1000) 1000
retrospective studies (984) 984
cardiovascular risk (983) 983
comorbidity (971) 971
population (950) 950
myocardial-infarction (930) 930
liver (918) 918
studies (912) 912
research article (901) 901
time factors (892) 892
lipid metabolism (885) 885
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (16) 16
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - Online (2) 2
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19846) 19846
Spanish (722) 722
Portuguese (376) 376
Russian (284) 284
French (271) 271
Chinese (207) 207
Japanese (159) 159
Czech (121) 121
Polish (95) 95
German (94) 94
Korean (83) 83
Italian (46) 46
Hungarian (32) 32
Croatian (17) 17
Turkish (17) 17
Romanian (15) 15
Slovak (14) 14
Ukrainian (13) 13
Persian (12) 12
Lithuanian (9) 9
Swedish (6) 6
Danish (4) 4
Finnish (4) 4
Slovenian (4) 4
Serbian (3) 3
Dutch (2) 2
Hebrew (2) 2
Icelandic (2) 2
Indonesian (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Greek (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Web Resource
2019, ISBN 9781496347442
"Dyslipidemia: A Clinical Approach is intended as a low-cost, quick-reference, easy-to-navigate guide for a broad range of healthcare professionals that will... 
Dyslipidemias | therapy | diagnosis
Web Resource
Journal Article
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 338 - 350
BACKGROUND:The PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor evolocumab reduced low-density lipoprotein cholesterol and cardiovascular events... 
atherosclerosis | amputation | cholesterol, LDL | evolocumab | peripheral arterial disease | PCSK9 protein, human | intermittent claudication | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | LIMB ISCHEMIA | ATORVASTATIN | STATIN THERAPY | AMPUTATION-FREE SURVIVAL | PERIPHERAL VASCULAR DISEASE | POLYVASCULAR DISEASE | PEOPLE | SIMVASTATIN | ASSOCIATION | Dyslipidemias - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Serine Proteinase Inhibitors - therapeutic use | Dyslipidemias - blood | Time Factors | Serine Proteinase Inhibitors - adverse effects | Amputation | Peripheral Arterial Disease - blood | Cholesterol, LDL - blood | Female | Dyslipidemias - diagnosis | Dyslipidemias - drug therapy | Limb Salvage | Down-Regulation | Risk Factors | Treatment Outcome | Biomarkers - blood | Proprotein Convertase 9 - metabolism | Anticholesteremic Agents - adverse effects | Peripheral Arterial Disease - mortality | Peripheral Arterial Disease - therapy | Anticholesteremic Agents - therapeutic use | Peripheral Arterial Disease - diagnosis | Proprotein Convertase 9 - antagonists & inhibitors | Aged | Cholesterol, LDL | Care and treatment | Research | Peripheral vascular diseases | Cardiovascular diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 19, pp. 1997 - 2007
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
Abstract Objective Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, pp. e0153497 - e0153497
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of... 
DIAGNOSIS | AMERICAN ASSOCIATION | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | CONTROLLED ATTENUATION PARAMETER | MARKERS | STEATOHEPATITIS | MICRORNAS | HEPATIC STEATOSIS | EXPRESSION | PCR | Dyslipidemias - genetics | Up-Regulation | Liver - pathology | Cross-Sectional Studies | Dyslipidemias - complications | Non-alcoholic Fatty Liver Disease - genetics | Humans | Middle Aged | Male | Non-alcoholic Fatty Liver Disease - complications | Young Adult | Caenorhabditis elegans | Non-alcoholic Fatty Liver Disease - blood | Dyslipidemias - blood | Animals | Non-alcoholic Fatty Liver Disease - diagnosis | Adult | Female | MicroRNAs - blood | MicroRNAs - genetics | Dyslipidemias - diagnosis | Complications and side effects | MicroRNA | Fatty liver | Dyslipidemias | Physiological aspects | Genetic aspects | Research | Risk factors | Biotechnology | Correlation | Nuclear magnetic resonance--NMR | Transplants & implants | Liver | Dyslipidemia | Feasibility analysis | Liver cancer | Hepatitis | Ultrasonic imaging | Bioindicators | Obesity | Liver diseases | Medical imaging | Feasibility studies | MiRNA | Inflammation | Metabolism | Gene expression | Patients | Low density lipoprotein | Cholesterol | Lipoproteins (very low density) | Steatosis | Serum levels | Cirrhosis | Weight control | Biopsy | MicroRNAs | Fibrosis | Biomarkers | Diagnostic systems | Diabetes | Methods | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Atherosclerosis, ISSN 0021-9150, 2011, Volume 219, Issue 2, pp. 425 - 431
Abstract Rationale Obstructive sleep apnea results in nocturnal intermittent hypoxia (IH) as a main trigger for cardiovascular morbidity, including... 
Cardiovascular | Intermittent hypoxia | Sleep apnea | Inflammation | Mice | Atherosclerosis | Dyslipidemia | OBSTRUCTIVE SLEEP-APNEA | MECHANISMS | DEFICIENT MICE | BLOOD-PRESSURE | EARLY SIGNS | CARDIOVASCULAR-DISEASE | CONSEQUENCES | PERIPHERAL VASCULAR DISEASE | HYPERTENSION | ASSOCIATION | Blood Pressure | Dyslipidemias - genetics | Inflammation - pathology | Plaque, Atherosclerotic - genetics | Apolipoproteins E - deficiency | Dyslipidemias - complications | Atherosclerosis - genetics | Aortic Diseases - blood | Male | Dyslipidemias - pathology | Inflammation - blood | Atherosclerosis - etiology | Dyslipidemias - blood | Time Factors | Diet, High-Fat | Lipids - blood | Inflammation Mediators - metabolism | Plaque, Atherosclerotic - blood | Plaque, Atherosclerotic - pathology | Aortic Diseases - pathology | Disease Models, Animal | Atherosclerosis - pathology | Atherosclerosis - physiopathology | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Hypoxia - complications | Inflammation - etiology | Cholesterol, Dietary - blood | Mice, Knockout | Plaque, Atherosclerotic - etiology | Plaque, Atherosclerotic - physiopathology | Atherosclerosis - blood | Aortic Diseases - genetics | Aortic Diseases - physiopathology | Hypoxia - blood | Hypoxia - genetics | Animals | Hypoxia - pathology | Apolipoproteins E - genetics | Inflammation - genetics | Hypoxia - physiopathology | Aortic Diseases - etiology | Dyslipidemias - physiopathology | Inflammation - physiopathology | Sleep apnea syndromes | Sleep | Index Medicus
Journal Article
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 2, pp. 129 - 169
Journal Article
2008, ISBN 9781846920295, xii, 297
Book
Circulation, ISSN 0009-7322, 01/2014, Volume 129, Issue 1, pp. 77 - 86
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 04/2018, Volume 103, Issue 4, pp. 712 - 721
Journal Article